RiboNova
PrivateLast Round
Grant
Dec 12, 2019
Total Funding Raised
$524,431
Company Overview
RiboNova is a biopharmaceutical company that develops small molecule drugs designed to treat serious rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RiboNova Comparables
Compare RiboNova with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ribometrix | 88% | |
| Base4 Biotechnology | 86% | |
| Expansion Therapeutics | 86% |
RiboNova Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 12, 2019 | ||||
| Grant | Dec 12, 2019 | ||||
| Seed | Jun 11, 2015 |
RiboNova Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioAdvance Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2019
$150K grant awarded by NIH RADx
RiboNova Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RiboNova's valuation, stock price, and market status.
Is RiboNova a public or private company?
RiboNova is a private company.
What is the current stock price of RiboNova?
RiboNova is a private company with no public stock price. No recent secondary market data is available.
How much is RiboNova worth (valuation)?
Valuation information for RiboNova is not publicly available.
Can I buy RiboNova stock?
RiboNova shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was RiboNova's last funding round?
RiboNova's most recent funding round was Seed on June 11, 2015.
Who are the main investors in RiboNova?
Key investors in RiboNova include BioAdvance Capital.
Will RiboNova IPO soon?
No public IPO plans have been announced for RiboNova.
How can I track RiboNova secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RiboNova's secondary market activity and sign up for updates.